Compare HDFC Pharma And Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.2
2.09
NAV
₹21.51
₹47.06
Fund Started
14 Sep 2023
25 Jun 2018
Fund Size
₹2611.33 Cr
₹6624.58 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
17.93%
6.41%
3 Year
-
24.51%
5 Year
-
15.50%
Equity
97.25%
96.05%
Cash
2.75%
3.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.96% |
Divi's Laboratories Ltd. | 7.16% |
Max Healthcare Institute Ltd. | 5.57% |
Lupin Ltd. | 5.26% |
Cipla Ltd. | 5.19% |
Aster DM Healthcare Ltd. | 5.05% |
Acutaas Chemicals Ltd. | 4.58% |
Alkem Laboratories Ltd. | 4.00% |
Anthem Biosciences Ltd. | 3.81% |
Ipca Laboratories Ltd. | 3.53% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
14 Sep 2023
25 Jun 2018
